Publication

Byline

किरन को आत्महत्या के लिए उकसाने वाला गिरफ्तार

कौशाम्बी, अप्रैल 7 -- चरवा के चकसाहबउद्दीनपुर गांव में रविवार को भैंस के खेत में जाने पर गांव के दबंग ने किसान व उसके परिजनों से मारपीट की थी। इससे आहत किसान की बेटी ने फांसी लगाकर आत्महत्या कर ली थी।... और पढ़ें


Akhilesh says 'drivers paid despite not operating buses'; SRTC junks claim as baseless

India, April 7 -- LUCKNOW Samajwadi Party chief Akhilesh Yadav has alleged corruption within the Uttar Pradesh State Road Transport Corporation (UPSRTC), claiming that drivers are receiving salaries d... और पढ़ें


सर्द-गरम मौसम में उखड़ने लगी लोगों की सांस, ओपीडी में पहुंचे 100 से अधिक

एटा, अप्रैल 7 -- सर्द-गरम मौसम में लोगों की सांख उखड़ने लगी है, जिससे सांस लेने में दिक्कत होने पर मरीज मेडिकल कालेज में उपचार लेने को पहुंच रहे हैं। मंगलवार को टीबीसीडी ओपीडी में करीब 100 मरीज सांस ल... और पढ़ें


दो चरणों में होगा जनगणना कार्य

बांदा, अप्रैल 7 -- बांदा। अपर जिलाधिकारी वित्त एवं राजस्व कुमार धर्मेन्द्र की अध्यक्षता में कलक्ट्रेट सभागार में जनगणना को लेकर बैठक हुई। बैठक में उन्होंने कहा कि जनगणना दो चरणों में पूरी होगी। प्रथम ... और पढ़ें


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 7 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... और पढ़ें


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... और पढ़ें


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... और पढ़ें


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... और पढ़ें


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... और पढ़ें


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... और पढ़ें